D. E. Shaw & Co., Inc. Biotechnology

D. E. Shaw & Co., Inc.

  • $125 Billion
  • Q2 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
NVO
Novo Nordisk A S
PUT
$113 Million
1.64M
Q1 2025
Added 25.67%
MRNA
Moderna, Inc.
PUT
$104 Million
3.78M
Q2 2025
Added 32.42%
ARGX
Argenx Se
CALL
$34.1 Million
61.8K
Q2 2025
Reduced 47.0%
MRNA
Moderna, Inc.
CALL
$28.6 Million
1.04M
Q2 2025
Added 32.42%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$13.1 Million
25K
Q2 2025
Added 34.3%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$9.56 Million
18.2K
Q2 2025
Added 34.3%
NVO
Novo Nordisk A S
CALL
$8.46 Million
123K
Q1 2025
Added 25.67%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$6.99 Million
23.1K
Q2 2025
Added 13.11%
CRSP
Crispr Therapeutics Ag
CALL
$6.5 Million
134K
Q3 2024
Added 4.23%
ARGX
Argenx Se
PUT
$5.79 Million
10.5K
Q2 2025
Reduced 47.0%
BNTX
Bio N Tech Se
PUT
$3.94 Million
37K
Q1 2025
Added 70.33%
TGTX
Tg Therapeutics, Inc.
CALL
$3.86 Million
107K
Q2 2025
Added 90.76%
BMRN
Biomarin Pharmaceutical Inc
PUT
$3.3 Million
60K
Q2 2025
Added 104.38%
BNTX
Bio N Tech Se
CALL
$2.78 Million
26.1K
Q1 2025
Added 70.33%
CYTK
Cytokinetics Inc
CALL
$2.7 Million
81.6K
Q2 2025
Added 43.47%
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$2.6 Million
8.6K
Q2 2025
Added 13.11%
VRTX
Vertex Pharmaceuticals Inc
PUT
$2.23 Million
5K
Q2 2025
Reduced 72.08%
VRNA
Verona Pharma PLC
CALL
$1.86 Million
19.7K
Q2 2025
Added 130.49%
NVAX
Novavax Inc
PUT
$1.73 Million
275K
Q2 2025
Added 20.85%
NVAX
Novavax Inc
CALL
$1.68 Million
267K
Q2 2025
Added 20.85%
VRTX
Vertex Pharmaceuticals Inc
CALL
$1.6 Million
3.6K
Q2 2025
Reduced 72.08%
SRPT
Sarepta Therapeutics, Inc.
PUT
$1.48 Million
86.5K
Q2 2025
Added 101548.62%
INSM
Insmed Inc
PUT
$1.01 Million
10K
Q2 2025
Added 365.74%
ARWR
Arrowhead Pharmaceuticals, Inc.
PUT
$924,000
58.5K
Q4 2023
New holding
CYTK
Cytokinetics Inc
PUT
$918,000
27.8K
Q2 2025
Added 43.47%
ASND
Ascendis Pharma A/S
CALL
$863,000
5K
Q2 2025
Reduced 64.99%
BPMC
Blueprint Medicines Corp
PUT
$845,000
6.6K
Q1 2025
Added 7.51%
ARWR
Arrowhead Pharmaceuticals, Inc.
CALL
$747,000
47.3K
Q4 2023
New holding
AXSM
Axsome Therapeutics, Inc.
CALL
$688,000
6.6K
Q2 2025
Reduced 63.34%
VKTX
Viking Therapeutics, Inc.
CALL
$622,000
23.5K
Q2 2025
Reduced 37.03%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$521,000
1.6K
Q2 2025
Reduced 62.65%
APLS
Apellis Pharmaceuticals, Inc.
PUT
$392,000
22.7K
Q2 2025
New holding
BGNE
Bei Gene, Ltd.
CALL
$362,000
1.6K
Q2 2025
Added 12.54%
APLS
Apellis Pharmaceuticals, Inc.
CALL
$240,000
13.9K
Q2 2025
New holding
Filter Shares Options
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email